About this Event
The 22nd Annual Koch Institute Symposium on Tumor Heterogeneity and Drug Resistance will take place on Friday, June 21, 2024. This year's speaker lineup features a robust array of experts, both internal to MIT and from external institutions around the US and abroad, representing multiple scientific disciplines and technical approaches that seek to better understand patient-specific variation in cancer progression and response to therapy.
We cordially invite scientists, oncologists, and any other member of the biomedical community to join us in a day of engaging talks, stimulating conversations with colleagues, and of course camaraderie in our collective fight against cancer. As we explore issues ranging from divergent single-cell states and plasticity to mechanisms of resistance through signaling and epigenetics, please consider joining us at this year’s summer symposium hosted by MIT’s nationally recognized basic cancer center.
More details and the full agenda are available at the Koch Institute's website.
Session One: Linking Cancer Cell State to Function
Cédric Blanpain | Keynote Université Libre de Bruxelles
Karuna Ganesh Memorial Sloan Kettering Cancer Center
Sydney Shaffer University of Pennsylvania
Alex Shalek Koch Institute at MIT
<h4></h4>
Session Two: Integrating Genomics & Signaling in Tumor Drug Response
Paul Mischel Stanford University
Rameen Beroukhim Dana-Farber Cancer Institute and ?Harvard Medical School
Neal Rosen Memorial Sloan Kettering Cancer Center
Michael Yaffe Koch Institute at MIT
Katherine Chiappinelli
George Washington University
Event Venue & Nearby Stays
Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, United States
USD 0.00 to USD 199.00
